A study evaluating prognostic value of total cfDNA quantification in a Danish patients treated for metastatic colorectal cancer with with late-line cetuximab, irinotecan and everolimus.
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2016
At a glance
- Drugs Cetuximab (Primary) ; Everolimus (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 18 Oct 2016 New trial record